Saturday 17 October 2026
Export MDVLQ’s income statement to Excel — free account
MedAvail Holdings, Inc.
MDVLQ Healthcare Pharmaceutical Retailers
Revenue growth for five consecutive years.
0.00
0.00
NaN
Follow MDVLQ
| Jun '23 | Mar '23 | Dec '22 | Sep '22 | Older periods | |
|---|---|---|---|---|---|
| (164.77%) | (962.98%) | (238.69%) | (157.29%) |
+8 more TTM periods Free account |
|
Piotroski F-Score |
5 | 5 | 4 | 4 | |
| (111.18%) | (163.78%) | (133.61%) | (96.46%) | ||
ROIC |
(297.87%) | 0.00% | (214.88%) | (163.04%) | |
Return on Tangible Assets |
(194.70%) | (184.22%) | (204.81%) | (127.02%) | |
Average Days of Receivables |
2.46 | 1.74 | 3.42 | 42.23 | |
Free Cash Flow per Share |
(17.93) | (25.23) | (37.98) | (34.10) | |
Free Cash Flow |
(32.23) | (40.50) | (49.97) | (54.58) | |
Capital Expenditures |
(0.69) | (0.89) | (2.30) | (2.96) | |
| Other line items | |||||
Cash ROIC |
(81.42%) | (161.55%) | (132.39%) | (79.19%) | |
Accounts Receivable Turnover |
36.59 | 44.46 | 54.12 | 11.72 | |
Accounts Payable Turnover |
22.16 | 8.65 | 24.60 | 4.03 | |
Inventory Turnover |
5.18 | 5.91 | 6.37 | 3.43 | |
Average Days of Payables |
7.15 | 8.04 | 7.37 | 40.06 | |
Days of Inventory on Hand |
90.38 | 77.92 | 79.41 | 127.82 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
2.21% | 2.38% | 2.59% | 4.62% | |
Selling, General and Administrative Expense of Revenue |
71.93% | 73.13% | 74.20% | 134.55% | |
Share Based Compensation of Revenue |
4.89% | 5.41% | 5.33% | 10.22% | |
Interest Coverage |
(23.62) | (21.14) | (19.80) | (15.59) | |
Operating CF/Net income |
0.69 | 0.76 | 1.00 | 1.05 | |
Depreciation/Fixed assets |
6.81 | 6.59 | 11.22 | 0.66 | |
Capex/Depreciation |
(0.14) | (0.17) | (0.47) | (0.71) | |
Revenue per Share |
24.10 | 27.07 | 32.77 | 12.21 | |
Operating CF per Share |
(17.54) | (24.67) | (36.23) | (32.25) | |
Capex per Share |
(0.39) | (0.55) | (1.75) | (1.85) | |
Capex to Sales |
0.02 | 0.02 | 0.05 | 0.15 |
Columns are period end dates